You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

226 Results
Guidelines and Advice
Status: Current
ID: N/A
Version: N/A
Oct 2019
Guidelines and Advice
Status: Current
ID: GL 17-12
Version: N/A
Sep 2019
Guidelines and Advice
Status: Current
ID: pet 2019-1
Version: N/A
Nov 2019
Drug
Other Name(s): Unituxin®
Quick Link(s):
Drug Monograph
Jun 2023
Guidelines and Advice
Status: Current
Oct 2019
Regimen
Cancer Type:
Gynecologic, 
Cervix
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Pembrolizumab - Metastatic, Persistent, or Recurrent Carcinoma of the Cervix
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
pembrolizumab,
PACLitaxel,
CARBOplatin
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2023
Guidelines and Advice
Status: Current
ID: PET 2022-2
Jun 2023
Guidelines and Advice
Status: Current
ID: GL 1-14
Version: 3
Oct 2019
Guidelines and Advice
Status: Current
ID: GL END 5-13
Version: N/A
Jun 2023
Guidelines and Advice
Status: In-Review
ID: GL 5-3ORG
Version: 2
Apr 2019

Pages